| Julie Diane Hartz, MS | |
|
3333 Mendocino Ave Ste 240, Santa Rosa, CA 95403-3631 | |
| (707) 566-5201 | |
| (707) 566-5203 |
| Full Name | Julie Diane Hartz |
|---|---|
| Gender | Female |
| Speciality | Audiologist-hearing Aid Fitter |
| Location | 3333 Mendocino Ave Ste 240, Santa Rosa, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184785339 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AU847 (California) | Primary |
| 237600000X | Audiologist-hearing Aid Fitter | HA2074 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julie Diane Hartz, MS 3333 Mendocino Ave Ste 240, Santa Rosa, CA 95403-3631 Ph: (707) 566-5201 | Julie Diane Hartz, MS 3333 Mendocino Ave Ste 240, Santa Rosa, CA 95403-3631 Ph: (707) 566-5201 |
News Archive
Researchers from Duke University Medical Center have identified how nanoparticles from diesel exhaust damage lung airway cells, a finding that could lead to new therapies for people susceptible to airway disease.
Diagnosing Chronic Traumatic Encephalopathy (CTE) during life is crucial for developing therapies and for determining how common the disease is among individuals exposed to repetitive head impacts from contact sports, military service and physical violence.
In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug-one with no known medical potential-to a schedule IV drug such as prescription sleep aids, but with tighter control.
In an effort to better understand what happens during Amyotrophic Lateral Sclerosis (ALS), researchers at Umea University in Sweden have compared the impact of ALS on the eye and limb muscles.
› Verified 1 days ago